Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome

This study has been completed.
Information provided by:
St. Petersburg State Pavlov Medical University Identifier:
First received: October 17, 2005
Last updated: October 17, 2006
Last verified: October 2005
The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate, lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome

Condition Intervention
Drug: Anticonvulsants

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment

Further study details as provided by St. Petersburg State Pavlov Medical University:


Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

Alcohol dependence Alcohol withdrawal syndrome

Exclusion Criteria:

Drug dependence Major psychiatric diagnoses Severe somatic illness

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00241995

Sponsors and Collaborators
St. Petersburg State Pavlov Medical University
Principal Investigator: Evgeny M Krupitsky, MD, PhD St. Petersburg State Pavlov Medical University
  More Information Identifier: NCT00241995     History of Changes
Other Study ID Numbers: RCT-RCT_LOND_GAT_AWS_2003
Study First Received: October 17, 2005
Last Updated: October 17, 2006

Additional relevant MeSH terms:
Anticonvulsants processed this record on April 28, 2017